<DOC>
	<DOCNO>NCT01743911</DOCNO>
	<brief_summary>Left ventricle diastolic dysfunction ( LVDD ) associate resistant hypertension . In addition , brain natriuretic peptide ( BNP ) level elevate LVDD present . It show phosphodiesterase-5 ( PDE5 ) inhibition improve leave ventricle diastolic function hypertensive rat , despite difference blood pressure level . Also , leave ventricle diastolic function enhancement reduces BNP concentration hypertensive patient . However , unknown effect exist human resistant hypertension . Therefore , study develop evaluate use PDE5 inhibitor ( tadalafil ) 2 week improve LVDD effect BNP level resistant hypertensive patient .</brief_summary>
	<brief_title>Tadalafil Effects Left Ventricle Diastolic Dysfunction Resistant Hypertensive Patients</brief_title>
	<detailed_description>Resistant hypertensive patient high incidence leave ventricle diastolic dysfunction ( LVDD ) . Lowering blood pressure level improve diastolic function , however , prove effective treatment specifically disease . Studies hypertensive rat show presence phosphodiesterase-5 cardiac cell improvement leave ventricle diastolic function use phosphodiesterase-5 ( PDE5 ) inhibitor , sildenafil . PDE5 also demonstrate human heart cell cardiac disease . In addition , LVDD associate high level brain natriuretic peptide ( BNP ) , reduce diastolic function improvement . Therefore , reasonable suppose PDE-5 inhibitor use human LVDD resistant hypertension could improve diastolic function . Objective : Evaluate chronic effect PDE-5 inhibitor LVDD BNP level resistant hypertensive patient . Casuistic method : 20 resistant hypertensive patient LVDD type I II evaluate echocardiography study , ambulatory blood pressure monitoring ( ABPM ) , office blood pressure measurement , endothelial function analysis use brachial artery flow mediation dilation technique ( FMD ) BNP plasma level . Then , subject receive oral placebo 2 week . After period , exams repeat . Two week later , protocol perform 20 patient , use tadalafil ( long half-life PDE-5 inhibitor ) 20mg orally instead placebo . Hypothesis : investigator hypothesize use tadalafil improve leave ventricle diastolic function BNP reduce level effect independent blood pressure decrease endothelial function improvement .</detailed_description>
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Phosphodiesterase 5 Inhibitors</mesh_term>
	<mesh_term>Tadalafil</mesh_term>
	<criteria>resistant hypertension ( accord Resistant Hypertension American Heart Association Statement 2008 ) ; compliance antihypertensive treatment ; age &gt; 35 year ; leave ventricle diastolic dysfunction type I II valvulopathy decompensated heart failure important cardiac arrhythmia nephropathy hepatopathy autoimmune disease tabagism decompensated diabetes uncontrolled dislipidemia</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2012</verification_date>
	<keyword>Tadalafil</keyword>
	<keyword>Resistant Hypertension</keyword>
	<keyword>Left Ventricle Diastolic Dysfunction</keyword>
	<keyword>Brain natriuretic peptide</keyword>
</DOC>